OpenAlex
PricingAboutJobs
Log inGet started
Work

Abstract 6240: A phase 1 study of selective PI3Kγ inhibitor ZX-4081 in patients with advanced solid tumors

HTML

Year: 2022
Type: conference-abstract
Source: Cancer Research
DOI: 10.1158/1538-7445.am2022-6240
Authors: Xiaoli Qin, Edgar Bautista, Ying-ying Li, Xiaomin Li, Zhiyuan Peng, Deming Kong, Jinfu Yang, Xiaolin Hao
Institution: Nanjing Zenshine Pharmaceuticals Co., Ltd. (China)
Language: English

Topic: PI3K/AKT/mTOR signaling in cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: PI3Kγ inhibitor, advanced solid tumors, myeloid cell activation, tumor microenvironment, CD8+ T cells, M1-like macrophages, immune checkpoint inhibitor resistance, antitumor immunity, 4T1 breast cancer, CT26 cells, pharmacokinetics, pharmacodynamics, safety and tolerability, dose escalation
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4282968097
Cites:
Cited by: 1
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security